Gastroenteroloji

Bayındır İçerenköy Hastanesi

Bayındır İçerenköy Hastanesi

Eğitim

Kariyer

Üyelikler

Yayınlar

Uluslararası Hakemli Dergilerde Yayınlanan Makaleler (SCI & SSCI & Arts and Humanities)

7.1.1. The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates.

Koyuncu Sokmen B, Sahin T, Oral A, Kocak E, Inan N.Sci Rep. 2021 Feb 24;11(1):4507. doi: 10.1038/s41598-021-83871-0.PMID:33627704

7.1.2. Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?

Türker F, Oral A, Sahin T, Türker BÇ, Koçak E, Ataoğlu HE, Ahbab S. J Int Med Res. 2021 Nov;49(11):3000605211056841. doi: 10.1177/03000605211056841.PMID:34763561

7.1.3. Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis.

Türker F, Sahin T, Oral A, Koçak E, Çavuşoğlu Türker B, Niğdelioğlu A, Esra Ataoğlu H.Int J Gen Med. 2022 Jan 25;15:859-865. doi: 10.2147/IJGM.S339474. eCollection 2022.PMID:35115812

7.1.4. Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?

Sahin T, Oral A, Turker F, Kocak E.Medicine (Baltimore). 2020 Mar;99(11):e19492. doi: 10.1097/MD.0000000000019492. PMID: 32176089

7.1.5. The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates.

Sahin T, Arikan BT, Serin A, Emek E, Bozkurt B, Server S, Dibekoglu C, Tokat Y. Transplant Proc. 2019 Sep;51(7):2383-2386. Doi: 10.1016/j.transproceed.2019.01.177. Epub 2019 Aug 8. PMID: 31402248

7.1.6. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.

Sahin T, Serin A, Emek E, Bozkurt B, Arikan BT, Tokat Y. Transplant Proc. 2019 Sep;51(7):2397-2402. doi: 10.1016/j.transproceed.2019.01.193. Epub 2019 Aug 8.PMID: 31402255

7.1.7. Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma.

Oral A, Sahin T. Sci Rep. 2019 Dec 13;9(1):19087. doi: 10.1038/s41598-019-55685-8.PMID:31836844

7.1.8. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients.

Oral A, Sahin T, Turker F, Kocak E. Medicina (Kaunas). 2019 Sep 17;55(9):600. doi: 10.3390/medicina55090600.PMID: 31533345

7.1.9. Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study.

Oral A, Sahin T, Turker F, Kocak E. Med Sci Monit. 2019 Dec 23;25:9882-9886. doi: 10.12659/MSM.920172.PMID: 31868169

7.1.10. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey.

Serin A, Sahin T, Arikan BT, Emek E, Bozkurt B, Tokat Y.Transplant Proc. 2019 Sep;51(7):2416-2419. doi: 10.1016/j.transproceed.2019.01.190. Epub 2019 Aug 8. PMID: 31402253

7.1.11. Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.

Serin A, Sahin T, Emek E, Arikan T, Koculu S, Yazici P, Mammadov E, Yuzer Y, Tokat Y. Transplant Proc. 2019 Sep;51(7):2482-2485. doi: 10.1016/j.transproceed.2019.02.043. Epub 2019 Aug 9.PMID: 31405736

7.1.12.  Liver Graft Volume Estimation by Manual Volumetry and Software-Aided Interactive Volumetry: Which is Better?

Bozkurt B, Emek E, Arikan T, Ceyhan O, Yazici P, Sahin T, Mammadov E, Serin A, Gurcan NI, Yuzer Y, Tokat Y.Transplant Proc. 2019 Sep;51(7):2387-2390. doi: 10.1016/j.transproceed.2019.01.152. Epub 2019 Jul 16. PMID:3132448

7.1.13. Analysis of the Liver Transplant Waiting List in Our Center.

Emek E, Yesim Kara Z, Demircan FH, Serin A, Yazici P, Sahin T, Tokat Y, Bozkurt B. TransplantProc. 2019 Sep;51(7):2413-2415. doi: 10.1016/j.transproceed.2019.01.192.PMID: 31474297

7.1.14.  Novel Application of Internal-External Drainage Catheter as Biliary Stent for Percutaneous Transhepatic Treatment of Biliary Strictures in Living Donor Liver Transplantation Recipient Patients.

Server S, Sabet S, Sahin T, Guven K, Aydın U, Tokat Y, Inan N.Transplant Proc. 2019 Sep;51(7):2469-2472. doi: 10.1016/j.transproceed.2019.01.153. Epub 2019 Aug 9. PMID:31405740

7.1.15. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.

Emek E, Serin A, Sahin T, Yazici P, Yuzer Y, Tokat Y, Bozkurt B.Transplant Proc. 2019 Sep;51(7):2439-2441. doi: 10.1016/j.transproceed.2019.01.156. Epub 2019 Aug 9. PMID:31405746

7.1.16.  Does Multiple Bile Duct Anastomosis in Living Donor Liver Transplantation Affect the Postoperative Biliary Complications?

Arikan T, Emek E, Bozkurt B, Mammadov E, Ceyhan O, Sahin T, Dibekoglu C, Serin A, Aydin U, Tokat Y.Transplant Proc. 2019 Sep;51(7):2473-2477. doi: 10.1016/j.transproceed.2019.01.160. Epub 2019 Aug 9. PMID: 31405743

7.1.17. Utility of Polyethylene Terephthalate (Dacron) Vascular Grafts for Venous Outflow Reconstruction in Living-Donor Liver Transplantations.

Arikan T, Mammadov E, Emek E, Bozkurt B, Inan Gurcan N, Yazici P, Sahin T, Serin A, Aydin U, Tokat Y. Transplant Proc. 2019 Sep;51(7):2442-2445. doi: 10.1016/j.transproceed.2019.02.040. Epub 2019 Aug 9.PMID: 31405738

7.1.18. Rabbit syndrome developing during peginterferon alfa-2a use in chronic hepatitis C.

Soyer OM, Pehlivan A, Ormeci AC, Baran B, Sahin T. Curr Med Res Opin. 2017 Jan;33(1):55-56. doi: 10.1080/03007995.2016.1233100. Epub 2016 Sep 14. PMID: 27595306

Uluslararası Diğer Hakemli Dergilerde Yayınlanan Makaleler

7.2.1. The safety of alpha fetoprotein in diagnosis of hepatocellular carcinoma in patients with type 2 diabetes mellitus.

Sahin T., Kocak E. Annals of Medical Research, 26(12), 2961- 2965., Doi: 10.5455/annalsmedres.2019.09.573

7.2.2.  Evaluation of relationships between clinical and radiological characteristics and tumor markers in hepatocellular carcinoma.

Oral A., Sahin T. Annals of Medical Research, 26(12), 2767-2770., Doi: 10.5455/annalsmedres.2019.09.569

7.2.3.  Retrospective evaluation of 220 patients diagnosed with nonalcoholic fatty liver disease by liver biopsy.

Oral A., Sahin T. International Anatolia Academik Online Journal-Health Sciences, 6(1), 50-64.

Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında (Proceedings) Basılan Bildiriler

7.3.1.  The predictive value of radiological, histological findings and Milan criteria in hepatocellular carcinoma recurrence after liver transplantation.

Sahin T. 2.International Hippocrates Congress, 194-195., 2020. (Özet bildiri).

7.3.2. Diagnostic Performance of MRI Texture Analysis in Prediction of Microvascular Invasion in HCCs of Pre-transplant Patients.

Sabet S.,Server S.,Sahin T., Aydin U.,İnan N., Tokat Y., Yüzer Y. (2019). International liver transplantation society congress 2019.

Yazılan Uluslararası Kitaplar veya Kitaplarda Bölümler

7.4.1. Güncel Genel Dahiliye Çalışmaları - II, Bölüm adı:(Crohn Hastalığı Epidemiyoloji, Tanı ve Medikal Tedavi) (2019). TOLGA ŞAHİN , AKADEMİSYEN KİTABEVİ, Editör:Ali Kemal KADİROĞLU, Basım sayısı:1, Sayfa Sayısı 19, ISBN:978-605-258-566-5, Türkçe(Bilimsel Kitap)

7.4.2. Güncel Genel Dahiliye Çalışmaları - II, Bölüm adı:(Ülseratif kolit Epidemiyoloji, Tanı ve Medikal Tedavi) (2019). TOLGA ŞAHİN , AKADEMİSYEN KİTABEVİ, Editör:Ali Kemal KADİROĞLU, Basım sayısı:1, Sayfa Sayısı 16, ISBN:978-605-258-566-5, Türkçe(Bilimsel Kitap)

Ulusal Hakemli Dergilerde Yayınlanan Makaleler

7.5.1.  Evaluation of Liver Fibrosis by Ten Noninvasive Methods in Patients with Chronic Hepatitis B: A Comparative Study.

Sahin T., Suleymanlar I. Akdeniz Tıp Dergisi, 4(1), 18- 24., Doi: 10.17954/amj.2018.111,

7.5.2. Kronik hepatit B ve BD kaynaklı sirozda, hepatoselüler karsinom gelişiminin öngörülmesinde ALBI ve PALBI skorlamalarının prediktif değeri.

Sahin T, Oral A. Namık Kemal Tıp Dergisi, 7(3), 172-179., (2019)

7.5.3. Hepatit B’ye bağlı siroz hastalarında hepatosellüler karsinom gelişiminde prediktif faktörlerin incelenmesi.

Sahin T, Oral A. Akademik Gastroenteroloji Dergisi, 18(3), 87-90., Doi: 10.17941/agd.654291.

7.5.4. A Rare Endoscopic Lesion Gastritis Cystica Polyposa.

Sahin T.Akdeniz Tıp Dergisi, 4(2), 193-196., Doi: 10.17954/amj.2018.131.

7.5.5. Hepatit C’ye bağlı siroz hastalarında hepatosellüler karsinom gelişiminde öngördürücü faktörlerin retrospektif analizi.

F Türker, B Çavuşoğlu, T Sahin. Anatolian Clinic the Journal of Medical Sciences 27 (2), 204-208

Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler

7.6.1. Karaciğer transplantasyonu alıcı adayı sirozlularda insülin direnci ve metabolik belirteçlerin etyolojik nedenler ile ilişkilerininin değerlendirilmesi.

Tolga Şahin. 12.Ulusal Hepatoloji Kongresi,161-162.

7.6.2. Hepatoselüler karsinomanın obesite ve metabolik belirteçlerle ilişkisi.

Ayfer Serin, Tolga Şahin. 3. Sağlık Bilimleri Üniversitesi Gastroenteroloji Günleri- 2019

7.6.3. Fundik gland polip saptanan olgularda proton pompa inhibitörü(PPI) kullanmayan hasta oranı.

Levent Kamil Erdem ,Tolga Şahin, Süleyman Uraz, Erdem Koçak, Gülen Doğusoy. (2019). 36.Ulusal Gastroenteroloji Haftası (UGH) Mezuniyet Sonrası Eğitim Toplantısı ve 7. Gastroenteroloji Cerrahisi Kongresi, 96-96.

7.6.4. Kadaverik karaciğer dağıtımında kullanılan skorlama sistemleri yeterli mi?

Ahmet Atasever, Sinan Efe Yazıcı, Gülçin Yanar, Nedret Özgür, Tolga Şahin, Levent Erdem, Nagihan Gürcan, Yıldıray Yüzer. 39. Ulusal Gastroenteroloji Haftası ve 10.Ulusal Gastroenteroloji Cerrahisi Kongresi. Sayfa: 84. Abstract No: 0450.

7.6.5. Hepatosellüler kanserde hasta seçiminde kullandığımız Barcelona Evreleme Sistemi Kriterleri prognoza etkili midir?

Sinan Efe Yazıcı, Ahmet Atasever, Gülçin Yanar, Nedret Özgür, Tolga Şahin, Levent Erdem, Nagihan Gürcan, Yıldıray Yüzer. 39. Ulusal Gastroenteroloji Haftası ve 10.Ulusal Gastroenteroloji Cerrahisi Kongresi. Sayfa: 85. Abstract No: 0469.

7.6.6. Hepatosellüler karsinom tanısıyla karaciğer nakli yapılan hastaların eksplant patolojik bulgularının sağkalım ve nüks üzerine etkileri.

Sinan Efe Yazıcı, Ahmet Atasever, Gülçin Yanar, Tolga Şahin, Levent Erdem, Bahar Ceyran, Yıldıray Yüzer (2022). 39. Ulusal Gastroenteroloji Haftası ve 10.Ulusal Gastroenteroloji Cerrahisi Kongresi. Sayfa: 88. Abstract No: 0488.

7.6.7. Karaciğer donör hepatektomide nadir görülen geç dönem komplikasyon: Akut mekanik obstruksiyon ile başvuran sağ diyafragmatik herni olgusu.

Sinan Efe Yazıcı, Ahmet Atasever, Nedret Özgür, Tolga Şahin, Levent Erdem, Nagihan Gürcan, Yıldıray Yüzer. 39. Ulusal Gastroenteroloji Haftası ve 10.Ulusal Gastroenteroloji Cerrahisi Kongresi. Sayfa: 28. Abstract No: 0434.

Uluslararası Atıflar

7.8.1 Relation Between Non-Alcoholic Fatty Pancreas and Clinical and Biochemical Parameters in Women with Polycystic Ovary Syndrome: A Multi-Centric Study. Osman MAA, Alkhouly M, Elmohaseb GF, Nassef EM, Mohamed IGR, El Mancy IM, Sabry S, Abdulrehim MM, Eliwa A, Eisa YH, Abdel-Ghany A, Abdelghani Y. Int J Gen Med. 2022 Nov 19;15:8225-8233. doi: 10.2147/IJGM.S384073. eCollection 2022. PMID: 36438020

7.8.2. Combined effect of pancreatic lipid content and gene variants (TCF7L2, WFS1 and 11BHSD1) on B-cell function in Middle Aged Women in a Post Hoc Analysis.. Nádasdi Á, Gál V, Masszi T, Patócs A, Igaz P, Somogyi A, Firneisz G. Diabetol Metab Syndr. 2022 Jul 27;14(1):106. doi: 10.1186/s13098-022-00876-z. PMID: 35897035

7.8.3. Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population. Liu HX, Ren YY, Meng CQ, Li Z, Nie Q, Yu CH, Ma HJ. Front Endocrinol (Lausanne). 2022 Aug 29;13:961803. doi: 10.3389/fendo.2022.961803. eCollection 2022. PMID: 36105392

7.8.4. Association between sensitivity to thyroid hormone indices and the risk of osteoarthritis: an NHANES study. Chen S, Sun X, Zhou G, Jin J, Li Z. Eur J Med Res. 2022 Jul 11;27(1):114. doi: 10.1186/s40001-022-00749-1. PMID: 35820977

7.8.5. Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma. Rios RS, et al. Chin Med J (Engl). 2021. PMID: 34855640

7.8.6. The Clinical Value of Thyroid Hormone Levels and Correlation with Severity of Liver Cirrhosis. Chang Liu , Li Li , Li Zeng. Comput Intell Neurosci. 2022 Jun 6;2022:5365172. doi: 10.1155/2022/5365172. eCollection 2022.

7.8.7. Effect of hypothyroidism on chronic liver diseases. Huan Liu; Peng Chen; Fei Li.- Journal of Clinical Hepatology, (12): 969-972, 2021. ID: wpr-875915

7.8.8. Relationship between hypothyroidism and cancer: literature review. Brazilian Journals Publicações de Periódicos, São José dos Pinhais, Paraná. Vol. 4 No. 1 (2021) https://doi.org/10.34119/bjhrv4n1-015

7.8.9.Contemporary strategies to assess and manage liver donor steatosis: a review. Tien, Christine; Remulla, Daphne; Kwon, Yong; Emamaullee, Juliet,. Current Opinion in Organ Transplantation: October 2021 - Volume 26 - Issue 5 - p 474-481. doi: 10.1097/MOT.0000000000000893

7.8.10. Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction.  Jaehyuk Choi , YoungRok Choi , Su Young Hong , Sanggyun Suh , Kwangpyo Hong , Eui Soo Han , Jeong-Moo Lee , Suk Kyun Hong , Nam-Joon Yi , Kwang-Woong Lee , Kyung-Suk Suh. Front Surg. 2022 May 3;9:827526. doi: 10.3389/fsurg.2022.827526. eCollection 2022.

7.8.11. Non-invasive tests for the prediction of primary hepatocellular carcinoma. Giovanni Marasco , Antonio Colecchia , Giovanni Silva , Benedetta Rossini , Leonardo Henry Eusebi , Federico Ravaioli , Elton Dajti , Luigina Vanessa Alemanni , Luigi Colecchia , Matteo Renzulli , Rita Golfieri , Davide Festi. World J Gastroenterol. 2020 Jun 28;26(24):3326-3343. doi: 10.3748/wjg.v26.i24.3326.

7.8.12. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". Koji Fujita , Tsutomu Masaki. J Clin Med. 2021 Jul 28;10(15):3340. doi: 10.3390/jcm10153340.

7.8.13. Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. Dagmara Przekop , Jakub Klapaczynski , Agnieszka Grytczuk , Ewa Gruszewska , Andrzej Gietka , Anatol Panasiuk  , Slawomir Golaszewski , Bogdan Cylwik , Lech Chrostek. J Clin Med. 2021 Aug 31;10(17):3951. doi: 10.3390/jcm10173951.

7.8.14. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma. M Omar , K Farid , T Emran , F El-Taweel , A Tabll , M Omran. Br J Biomed Sci . 2021 Apr;78(2):72-77. doi: 10.1080/09674845.2020.1832371. Epub 2020 Nov 18.

7.8.15. Diagnostic and prognostic value of serum Chitinase 3-like protein 1 in hepatocellular carcinoma. Shuwei Wang , Shixiang Chen , Ming Jin , Mengyuan Hu , Weiguang Huang , Zhenluo Jiang , Jianuo Yang , Yecheng Zhang , Haoming Wu , Yaoren Hu , Weixin He , Liyun Fu. J Clin Lab Anal. 2022 Feb;36(2):e24234. doi: 10.1002/jcla.24234. Epub 2022 Jan 16.

7.8.16. Effects of peer education on psychological  stress, attitude towards disease and treatment  compliance in patients with chronic hepatitis B. Chenxi Xia, Xingxing Li, Ying Zheng. Int J Clin Exp Med 2021;14(1):415-422

7.8.17. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Xinhe Zhang , Lin Guan , Haoyu Tian , Zilu Zeng , Jiayu Chen , Die Huang , Ji Sun , Jiaqi Guo , Huipeng Cui , Yiling Li. Front Oncol. 2021 Sep 9;11:686962. doi: 10.3389/fonc.2021.686962. eCollection 2021.

7.8.18. ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. Ollivier-Hourmand I, et al. Liver Int. 2022 Jun;42(6):1386-1400. doi: 10.1111/liv.15159. Epub 2022 Jan 17.7.3.

7.8.19. Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Mohkam K , Abdallah R,  N'kontchou G, Ganne N, Barbier L , Salamé E , Bucur P, Rayar M , Robin F , Boudjema K , Pietrasz D , Cherqui D , Adam R , Lim C , Savier E,  Scatton O , Maulat C, Suc B , Muscari F, Laurent A , Duvoux C , Heyd B , Turco C, Doussot A, Merle P, Antonini T , Lesurtel M , Cossé C, Durand F, Soubrane O, Cauchy F, Mabrut YV , ACHBT French research group. Transplantation. 2022 Jul 1;106(7):1411-1420. doi: 10.1097/TP.0000000000004004. Epub 2021 Dec 27.

7.8.20. Distribution of ABO Blood Groups and Their Association With Low Risk of Severe COVID-19 Infection in Patients. M Peng, S Huang, Q Lv, C Chen, J Qin, M He, J Yang. 2021 - researchsquare.com. https://doi.org/10.21203/rs.3.rs-139563/v1

7.8.21. Kanser Hastalarında ABO ve Rhesus Kan Gruplarının Dağılımı. İnci F., Karataş F. Journal of Uludag Medical Faculty. Year 2020, Volume 46, Issue 3, 379 - 384, 01.12.2020. https://doi.org/10.32708/uutfd.812217

7.8.22. The relationship between blood groups and plateletcrits in healthy Turkish population. Özbalcı D., Alanoglu E.G., Baş Y.F., Tatar N, Özkan Y, Yasan H, Kaya E. Med J SDU / SDÜ Tıp Fak Derg u 2022:29(3):314-323 doi: 10.17343/sdutfd.1073876

7.8.23. The Relationship between the Glycosilation of the Sars-Cov-2 Spike Protein and ABO System Blood Groups. Oliveira LF. London Journal of Research in Science: Natural and Formal Volume 22 | Issue 1 | Compilation 1.0

7.8.24. Association of the ABO blood group with certain human diseases Liu S, Yang X, Wang G. Blood and Genomics 2020, 4(2): 108-114.  https://doi.org/10.46701/BG.2020022020108

7.8.25. Association between ABO blood type and prognosis in patients with HBV-related hepatocellular carcinoma after hepatectomy[J]. Xiumei L, Yanji J, Zewen Z, Jialin Q, Wenfeng G, Liang MA, Bangde X, Weizhong T , Hongping YU, Zihan Z. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 282-287. doi: 10.3969/j.issn.1674-5671.2021.03.11

7.8.26. Correlation between ABO blood type and risk of liver cancer: a meta-analyses . Jun AI, Jia-juan Z, Wen-kai Z, Ping LI. Chinese Hepatolgy,2021, Vol. 26  Issue (7): 765-769.

7.8.27. Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes .Ye T, Lin L, Cao L, Huang W,  Wie S, Shan Y, Zhang Z. Front Oncol. 2022; 12: 863266. PMCID: PMC9168273. PMID: 35677150. doi: 10.3389/fonc.2022.863266

7.8.28. Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver disease. Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Yamamoto A, Takahashi K, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Oyamada S, Kobayashi N, Aishima S, Saito S, Nakajima A, Yoneda M. JGH Open. 2022 Aug 24;6(10):696-703. doi: 10.1002/jgh3.12808. eCollection 2022 Oct. PMID: 36262543

7.8.29. Hepatic glycerol shunt and glycerol-3-phosphate phosphatase control liver metabolism and glucodetoxification under hyperglycemia. Al-Mass A, Poursharifi P, Peyot ML, Lussier R, Chenier I, Leung YH, Ghosh A, Oppong A, Possik E, Mugabo Y, Ahmad R, Sladek R, Murthy Madiraju SR, Al-Mulla F, Prentki M. Mol Metab. 2022 Oct 2;66:101609. doi: 10.1016/j.molmet.2022.101609. Online ahead of print. PMID: 36198384

7.8.30. Improving the accuracy of fatty liver index to reflect liver fat content with predictive regression modelling. Asaturyan HA, Basty N, Thanaj M, Whitcher B, Thomas EL, Bell JD. PLoS One. 2022 Sep 13;17(9):e0273171. doi: 10.1371/journal.pone.0273171. eCollection 2022. PMID: 36099244

7.8.31. Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning. Wang C, Yan J, Zhang S, Xie Y, Nie Y, Chen Z, Xu S. Front Med (Lausanne). 2022 Jun 9;9:771219. doi: 10.3389/fmed.2022.771219. eCollection 2022. PMID: 35755070

7.8.32. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before Operation. Yu M, Zhang C, Tang H, Xiao C. J Healthc Eng. 2022 Apr 11;2022:1964866. doi: 10.1155/2022/1964866. eCollection 2022. PMID: 35449838

7.8.33. Correlation between serum total bile acid and nonalcoholic fatty liver disease: A cross-sectional study. Chen Y, Su H, Xue H, Wang T, Qian T, Liao C, Wu J. Saudi J Gastroenterol. 2022 Jul-Aug;28(4):304-311. doi: 10.4103/sjg.sjg_512_21. PMID: 35170435

7.8.34. Exploration of the Effect on Genome-Wide DNA Methylation by miR-143 Knock-Out in Mice Liver. Chen X, Luo J, Liu J, Chen T, Sun J, Zhang Y, Xi Q. Int J Mol Sci. 2021 Dec 3;22(23):13075. doi: 10.3390/ijms222313075. PMID: 34884879

7.8.35. Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS. Goon DE, Ab-Rahim S, Mohd Sakri AH, Mazlan M, Tan JK, Abdul Aziz M, Mohd Noor N, Ibrahim E, Sheikh Abdul Kadir SH. Sci Rep. 2021 Oct 25;11(1):21001. doi: 10.1038/s41598-021-00454-9. PMID: 34697380

7.8.36. A Population Based Study of Liver Function amongst Adults with Hyperuricemia and Gout in the United States. Deb S, Sakharkar P. Diseases. 2021 Sep 17;9(3):61. doi: 10.3390/diseases9030061. PMID: 34562968

7.8.37. Fructose and the Liver. Muriel P, López-Sánchez P, Ramos-Tovar E. Int J Mol Sci. 2021 Jun 28;22(13):6969. doi: 10.3390/ijms22136969. PMID: 34203484

7.8.38. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. Chrysavgis L, Ztriva E, Protopapas A, Tziomalos K, Cholongitas E. World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514. PMID: 33268944

7.8.39. Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review. Brennan P, Clare K, George J, Dillon JF. World J Gastroenterol. 2020 Apr 21;26(15):1683-1690. doi: 10.3748/wjg.v26.i15.1683. PMID: 32351286

7.8.40. Purine metabolites and complex diseases: role of genes and nutrients Nelson, Kendra L.; Voruganti, Venkata Saroja. Current Opinion in Clinical Nutrition and Metabolic Care: July 2021 - Volume 24 - Issue 4 - p 296-302 doi: 10.1097/MCO.0000000000000764

7.8.41. Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study. Wanlu Su,Yuxia Wang,Kang Chen,Jie Wang,Anping Wang,Xulei Tang,Li Yan,Zuojie Luo,Guijun Qin,Lulu Chen,Guang Ning,Yiming Mu. Journal of Diabetes. Volume13, Issue6, June 2021 Pages 494-505. https://doi.org/10.1111/1753-0407.13134

7.8.42. Obese female mice do not exhibit overt hyperuricemia despite hepatic steatosis and impaired glucose tolerance. Sara E. Lewis, Lihua Li, Marco Fazzari, Sonia R. Salvatore, Jiang Li, Emily A.Hileman, Brooke A. Maxwell, Francisco J.Schopfer, Gavin E.Arteel, Nicholas K.H.Khoo, Eric E.Kelley. Advances in Redox Research Volume 6, December 2022, https://doi.org/10.1016/j.arres.2022.100051

7.8.43. Exploration of the Effect on Genome-Wide DNA Methylation by miR-143 Knock-Out in Mice Liver. Chen X , Luo J , Liu J , Chen T , Sun J , Zhang Y, Xi Q. Int J Mol Sci . 2021 Dec 3;22(23):13075. doi: 10.3390/ijms222313075.

7.8.44. Influence of Uric acid Levels on Pegylated Interferon Plus Ribavirin Therapy in Patients with Chronic Hepatitis C. Serhat Özer, Zeynep Altın, Sinem Namdaroglu, Betül Koyuncu, Fatih Aslan, and Belkıs Ünsal. International Journal of Hepatology & Gastroenterology.Volume 6 issue 1. S(10-17).

7.8.45. Risk Factors and Frequency of Non-Alcoholic Fatty Liver Disease Amongst Non-Obese Individuals.Usman M, Yaqoob Y, Anjum MA, Hussain A, Ahmad A, Ayyaz M. P J M H S  Vol. 15, NO. 3, MARCH  2021

7.8.46. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Yin H, Shi A, Wu J. Diabetes Metab Syndr Obes. 2022 Jul 8;15:2003-2030. doi: 10.2147/DMSO.S367483. eCollection 2022. PMID: 35837578 Review.

7.8.47. Early changes in laboratory tests predict liver function damage in patients with moderate coronavirus disease 2019: a retrospective multicenter study. Wang Y, Gao D, Li X, Xu P, Zhou Q, Yin J, Xu J. BMC Gastroenterol. 2022 Mar 9;22(1):113. doi: 10.1186/s12876-022-02188-y. PMID: 35264110

7.8.48. Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients. Michalak A, Cichoż-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W. Biomed Res Int. 2021 Feb 15;2021:8867985. doi: 10.1155/2021/8867985. eCollection 2021. PMID: 33644233 

7.8.49. Fully automated preoperative liver volumetry incorporating the anatomical location of the central hepatic vein. Koitka S, Gudlin P, Theysohn JM, Oezcelik A, Hoyer DP, Dayangac M, Hosch R, Haubold J, Flaschel N, Nensa F, Malamutmann E. Sci Rep. 2022 Oct 1;12(1):16479. doi: 10.1038/s41598-022-20778-4. PMID: 36183002

7.8.50. Left lateral segment liver volume is not correlated with anthropometric measures. Brian I.Shaw, Fides R.Schwartz, Mariya L.Samoylova. Andrew S.Barbas, Lisa M. McElroy, Carl Berg, Debra L.Sudan, Daniele Marin, Kadiyala V. Ravindra. HPB Volume 23, Issue 12, December 2021, Pages 1830-1836. https://doi.org/10.1016/j.hpb.2021.04.018

7.8.51. Knowledge levels, attitudes, and awareness of nurses toward organ donation. Akbulut S, Demyati K, Tamer M, Unsal S, Beyoglu S, Saritas H. North Clin Istanb. 2022 Sep 2;9(4):367-375. doi: 10.14744/nci.2022.24478. eCollection 2022. PMID: 36276570

7.8.52. Attitudes, awareness, and knowledge levels of the Turkish adult population toward organ donation: Study of a nationwide survey. Akbulut S, Ozer A, Gokce A, Demyati K, Saritas H, Yilmaz S. World J Clin Cases. 2020 Jun 6;8(11):2235-2245. doi: 10.12998/wjcc.v8.i11.2235. PMID: 32548154

7.8.53. Attitudes, knowledge levels and behaviors of Islamic religious officials about organ donation in Turkey: National survey study. Akbulut S, Ozer A, Firinci B, Saritas H, Demyati K, Yilmaz S. World J Clin Cases. 2020 May 6;8(9):1620-1631. doi: 10.12998/wjcc.v8.i9.1620. PMID: 32432140

7.8.54. Biliary complications after adult to adult right-lobe living donor liver transplantation (A-ARLLDLT): Analysis of 245 cases during 16 years period at a single high centre- A retrospective cohort study Hamdy Gad, Eslam Ayoup, Amr M.Aziz, Tarek Ibrahim, Mostafa Elhelbawy, Mohammed Al-sayed Abd-elsamee,  Ahmed Nabil Sallam. Annals of Medicine and Surgery Volume 77, May 2022, 103577. https://doi.org/10.1016/j.amsu.2022.103577

7.8.55. Short-term results of percutaneous transhepatic interventions for anastomotic biliary strictures after living donor liver transplantation using a right lobe graft. Popov MV, Sergey E. Voskanyan, Artemiev A.I., Alexander I. Sushkov, Moisey S. Aronov, Kolyshev I.Yu., Shcherbin V.V., Mal’tseva A.P., Vladimir S. Rudakov, Andrey N. Bashkov , Sadykhov Z.A., Muktarzhan M.U. Clinical and Experimental Surgery. Petrovsky Journal. 2020; 8 (4): 143-53. DOI: https://doi.org/10.33029/2308-1198-2020-8-4-143-153

7.8.56. Two decades of research on autoimmune liver disease in Turkey. Demir N, Ekin N, Torgutalp M, Wahlin S, and Efe C. Turk J Gastroenterol. 2020 Dec; 31(12): 877–882. doi: 10.5152/tjg.2020.19866 PMCID: PMC7928254 PMID: 33626000

7.8.57. Geoepidemiologic variation in outcomes of primary sclerosing cholangitis. Mehta TI, Weissman S, Fung BM, Tabibian JH. World J Hepatol. 2020 Apr 27; 12(4): 116–124. doi: 10.4254/wjh.v12.i4.116. PMCID: PMC7336294 PMID: 32685104

7.8.58. Patterns and Features of Cholestatic Liver Diseases: Experience of a Tertiary Academic Center in Saudi Arabia. Hatim A Khatib, Hind I Fallatah, Majed A Al-Sahafi and Hisham O Akbar. Ann Med Health Sci Res. 2020;10: 1168-1172.

7.8.59. Thousand words about alcohol use disorder in inflammatory bowel disease. Journal of Medical Science Vol. 90 No. 1 (2021)DOI: https://doi.org/10.20883/medical.e506

7.8.60. Factors Affecting Bile Complications After Liver Transplantation: Single-Center Experience. Sevmis M, Zarbaliyev E, Yildiz H, Alkara U, Aktas S, Sevmis S. Sisli Etfal Hastan Tip Bul. 2022 Jun 28;56(2):227-231. doi: 10.14744/SEMB.2021.17362. eCollection 2022. PMID: 35990301

7.8.61. Biliary complications after adult to adult right-lobe living donor liver transplantation (A-ARLLDLT): Analysis of 245 cases during 16 years period at a single high centre- A retrospective cohort study. Gad EH, Ayoup E, Aziz AM, Ibrahim T, Elhelbawy M, Abd-Elsamee MA, Sallam AN. Ann Med Surg (Lond). 2022 Apr 14;77:103577. doi: 10.1016/j.amsu.2022.103577. eCollection 2022 May. PMID: 35638038

7.8.62. Optimal Endoscopic Management of Anastomotic Strictures After Double- Biliary Reconstruction in Right Lobe Living-Donor Liver Transplantation. Çağın YF, Erdoğan MA, Sağlam O, Yıldırım O, Bilgiç Y, Arslan AK, Sarıcı KB, Yılmaz S. Balkan Med J. 2021 Nov;38(6):348-356. doi: 10.5152/balkanmedj.2021.21692. PMID: 34860162

7.8.63. Cystic duct anastomosis can be a viable option for biliary reconstruction in case of multiple ducts in right lobe living-donor liver transplantation. Vijayashanker A, Chikkala BR, Ghimire R, Nidoni R, Pandey Y, Dey R, Agarwal S, Gupta S. Ann Hepatobiliary Pancreat Surg. 2021 Aug 31;25(3):328-335. doi: 10.14701/ahbps.2021.25.3.328. PMID: 34402432

7.8.64. The Application of Interventional Radiology in Living-Donor Liver Transplantation.

Ko GY, Sung KB, Gwon DI. Korean J Radiol. 2021 Jul;22(7):1110-1123. doi: 10.3348/kjr.2020.0718. Epub 2021 Mar 9. PMID: 33739630

7.8.65. Case report: Trans-papillary free stenting of the cystic duct and of the common bile duct in a double biliary ducts anastomoses of a right lobe living donor transplantation. Gruttadauria S, Tropea A, Pagano D, Calamia S, Ricotta C, Bonsignore P, Li Petri S, Cintorino D, di Francesco F. BMC Surg. 2021 Jan 19;21(1):44. doi: 10.1186/s12893-020-01045-7. PMID: 33468113

7.8.66. Hepatic vein in living donor liver transplantation. Balci D, Kirimker EO. Hepatobiliary & Pancreatic Diseases International Volume 19, Issue 4, August 2020, Pages 318-323https://doi.org/10.1016/j.hbpd.2020.07.002

7.8.67.Small-For-Size Syndrome and Graft Inflow Modulation Techniques in Liver Transplantation.  Cheng P, Li Z, Fu Z, Jian Q, Deng R, Ma Y. Digestive Diseases. https://doi.org/10.1159/000525540

7.8.68. Small-diameter polyurethane vascular graft with high strength and excellent compliance. Zhanga B, Xub Y, Mab S, Wang L, Liu C, Xu W , Shid J, Qiaod W, Yang H. Journal of the Mechanical Behavior of Biomedical Materials. Volume 121, September 2021, 104614.https://doi.org/10.1016/j.jmbbm.2021.104614

7.8.69. Construction of spider silk protein small-caliber tissue engineering vascular grafts based on dynamic culture and its performance evaluation. Sun L, Li X, Yang T, Lu T, Du P, Jing C, Chen Z, Lin F, Zhao G, Zhao L.Journal of Biomedical Materials Research. Volume111, Issue1 January 2023 Pages 71-87. https://doi.org/10.1002/jbm.a.37447

7.8.70. Atypical Placement of Left Lateral Segment in Living Donor Liver Transplantation. Chen MD; Gu, Lihong MD; Zhou Tao MD, Gu Guangxiang MD, Xia Qiang MD. Transplantation: November 2021 - Volume 105 - Issue 11 - p e274-e275. doi: 10.1097/TP.0000000000003848

Uzmanlık Alanları

-Gastroskopi (Polipektomi, Biyopsi)

-Kolonoskopi (Polipektomi, Biyopsi)

-ERCP, PEG Açılması

-Karaciğer Sirozu

-Kronik Viral Hepatitler (Hepatit B, C, D)

-İnflamatuvar Bağırsak Hastalıkları (Ülseratif Kolit, Crohn)

-Fonksiyonel Bağırsak Hastalıkları

-Çölyak Hastalığı

-Otoimmün Hepatitler

-Primer Biliyer Kolanjit

-Primer Sklerozan Kolanjit

-Özofagus Motilite ve Yutma Bozuklukları (Akalazya ve Diğerleri)

-Özofagus PHmetri ve Manometri Testleri

-Anorektal Manometri

-İleri Endoskopik İşlemler (POEM, ESD, EMR)

Ödüller

loading
x

Randevu Talebi Oluşturma

* listenenler dışındaki tarih ve saate randevu almak istiyorsanız lütfen 0850 911 0 911 numaralı çağrı merkezimiz ile iletişime geçebilirsiniz

Verdiğim kişisel veri ve iletişim bilgilerimin, Bayek Tedavi Sağlık Hizmetleri ve İşletmeciliği A.Ş., Penta Sağlık Hizmetleri A.Ş., Bayek Ağız ve Diş Sağlığı Hizmetleri ve İşletmeciliği A.Ş. (hepsi birlikte Bayındır Sağlık Grubu olarak anılacaktır) tarafından, 6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında Aydınlatma Metninde belirtilen amaç ve bağlı amaçlar dahilinde işlenmesine ve aktarılmasına muvafakatettiğimi beyan, kabul ve taahhüt ederim.

Bayek Tedavi Sağlık Hizmetleri ve İşletmeciliği A.Ş., Penta Sağlık Hizmetleri A.Ş., Bayek Ağız ve Diş Sağlığı Hizmetleri ve İşletmeciliği A.Ş. (hepsi birlikte Bayındır Sağlık Grubu olarak anılacaktır) tarafından her türlü bilgilendirme, etkinlik, duyuru, anket, tanıtım, açılış, davet vb. hatırlatmaları ile diğer sair iletişim çalışmaları kapsamında tarafıma ticari elektronik ileti (arama, SMS, e-posta vb.) gönderilmesini kabul ediyorum.

Lütfen Üstteki Kutucuğu işaretleyiniz!

Hastanemizde kaydınız var ise direkt randevu alabilmek için tıklayınız